Search This Blog

Tuesday, February 7, 2023

Novartis Says Sandoz's Prolia, Xgeva Biosimilar Accepted for Review in US

 https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Says-Sandoz-s-Prolia-Xgeva-Biosimilar-Accepted-for-Review-in-US-42906115/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)